CAPTRUST Financial Advisors’s The Oncology Institute Warrant TOIIW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,957
Closed -$3K 5132
2021
Q4
$3K Hold
3,957
﹤0.01% 4309
2021
Q3
$5K Hold
3,957
﹤0.01% 3962
2021
Q2
$7K Sell
3,957
-192
-5% -$258 ﹤0.01% 3723
2021
Q1
$6K Sell
4,149
-688
-14% -$1.28K ﹤0.01% 3676
2020
Q4
$9K Buy
+4,837
New +$8.34K ﹤0.01% 2635

Other funds holding TOIIW

CAPTRUST Financial Advisors's TOIIW Position: Q1 2022 in Review

CAPTRUST Financial Advisors sold out of The Oncology Institute Warrant (TOIIW) in Q1 2022, closing a stake of 3,957 shares — an estimated $3K sold.

CAPTRUST Financial Advisors first reported a position in TOIIW in Q4 2020 and held it in 5 quarters. The position peaked at $9K in Q4 2020. 12 funds tracked by Wall St. Rank hold TOIIW as of Q1 2022.

  • CAPTRUST Financial Advisors reported no remaining The Oncology Institute Warrant position as of Q1 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 3,957 The Oncology Institute Warrant shares in Q1 2022, an estimated $3K.
  • CAPTRUST Financial Advisors first reported a position in The Oncology Institute Warrant in Q4 2020 and held it in 5 quarters.
  • CAPTRUST Financial Advisors's The Oncology Institute Warrant position peaked at $9K in Q4 2020.
  • 12 funds tracked by Wall St. Rank held The Oncology Institute Warrant as of Q1 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2022, filed 16 May 2022.